Meet the New Big Proteostasis Licensing Agreement
Proteostasis Therapeutics shares jumped on Monday after the company announced that a new licensing agreement with Genentech.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 113
Texas Judge’s Ruling on Obamacare Torpedoes Hospital Stocks
A federal district court judge in Texas had declared the Affordable Care Act (aka, Obamacare) unconstitutional in a ruling that is taking a bite out of shares in insurance and hospital firms Monday.
Eli Lilly Scores Solid Results in Psoriatic Arthritis Study
Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study.
Vaping More Popular Than Ever Among US Teens
The percentage of U.S. teens who report using vaping devices is on the rise. Year over year, use by high school seniors rose by a third in 2018. But there's also some good news…
Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Close to 30 Million Newborns Need Immediate Medical Treatment Each Year
The World Health Organization reports close to 30 million babies with health problems require immediate care worldwide. And this is true every year.
Eli Lilly Receives Crucial FDA Update on Lupus Study
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Applied Genetic Technologies Suffers Setback in Eye Study
Applied Genetic Technologies shares dropped on Thursday after the company announced that its midstage eye study did not live up to expectations.
How Marinus Pharma Is Capitalizing on Its Depression Study Success
Marinus shares backed off on Wednesday when the firm announced that it would be conducting a secondary offering. The company is capitalizing on its success earlier this week when it announced positive results from…
Neurocrine Bio Stumbles on Tourette Study Results
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
Major Pharma Stocks See a Surge in Short Interest
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
CDC Warns About Dangers of Raw Cookie Dough
It is not unusual for people to eat raw cookie dough as they make the cookies. The habit should be avoided, according to the CDC.
Ra Pharmaceuticals Delivers on Midstage Muscle Study
Ra Pharmaceuticals shares jumped on Monday after the company announced positive mid-stage results for the treatment of generalized myasthenia gravis.
Marinus Scores Big With Midstage Depression Study
Marinus Pharmaceuticals shares made a handy gain on Monday after the company announced positive results from its midstage trial in women with postpartum depression.